Another experimental study demonstrated that both protein and mRNA levels of IL-22, IL-23, and IL-17 were enhanced in the peripheral blood of patients affected by SS [72], assuming that the IL-23/IL-17/IL-22 axis could be one of the key mediators in the pathogenesis of primary SS [70,72,73,74]. The gene discussed is IL17A; the disease is synovial sarcoma.